Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism

[1]  P. Manhem,et al.  Prolonged clonidine treatment: catecholamines, renin activity and aldosterone following exercise in hypertensives. , 2009, Acta medica Scandinavica.

[2]  E. Boerwinkle,et al.  Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. , 2001, Mayo Clinic proceedings.

[3]  J. Grose,et al.  Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism , 2001, Hypertension.

[4]  C. Gomez-Sanchez,et al.  Establishing a diagnosis of primary hyperaldosteronism , 2001 .

[5]  Lei Xu,et al.  Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  H. Raff,et al.  Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. , 2001, The Journal of clinical endocrinology and metabolism.

[7]  W. Young,et al.  Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. , 2000, The Journal of clinical endocrinology and metabolism.

[8]  C. Gomez-Sanchez,et al.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  R. Jung,et al.  High prevalence of primary aldosteronism in the Tayside hypertension clinic population , 2000, Journal of Human Hypertension.

[10]  W. Young,et al.  Primary aldosteronism: A common and curable form of hypertension. , 1999, Cardiology in review.

[11]  J. Laragh,et al.  β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects , 1999 .

[12]  S. Shankland,et al.  Cell Cycle Regulatory Proteins in Glomerular Disease , 1999, Nephron Experimental Nephrology.

[13]  R. Hopper,et al.  Calcium-channel blockade can mask the diagnosis of Conn's syndrome , 1999, Postgraduate medical journal.

[14]  X. Jeunemaître,et al.  Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. , 1998, The Journal of clinical endocrinology and metabolism.

[15]  M. Boscaro,et al.  Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. , 1998, The Journal of clinical endocrinology and metabolism.

[16]  F. Hayes,et al.  Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  M. Stowasser,et al.  HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION , 1994, Clinical and experimental pharmacology & physiology.

[18]  M. Stowasser,et al.  EVIDENCE THAT PRIMARY ALDOSTERONISM MAY NOT BE UNCOMMON: 12% INCIDENCE AMONG ANTIHYPERTENSIVE DRUG TRIAL VOLUNTEERS , 1993, Clinical and experimental pharmacology & physiology.

[19]  T. Mckenna,et al.  Evidence for a tonic inhibitory role of nifedipine-sensitive calcium channels in aldosterone biosynthesis , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  T. Mckenna,et al.  Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. , 1991, The Journal of clinical endocrinology and metabolism.

[21]  F. Cappuccio,et al.  Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. , 1991, Journal of human hypertension.

[22]  J. Colina-Chourio,et al.  Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein. , 1991, The American journal of cardiology.

[23]  R. Reeves,et al.  Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans. , 1987, The American journal of medicine.

[24]  J. Whitworth,et al.  ACUTE HAEMODYNAMIC AND HORMONAL EFFECTS OF ORAL DOXAZOSIN IN NORMAL SUBJECTS , 1987, Clinical and experimental pharmacology & physiology.

[25]  Melby Jc,et al.  The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism. , 1985 .

[26]  C. Gomez-Sanchez,et al.  Further evaluation of saline infusion for the diagnosis of primary aldosteronism. , 1984, Hypertension.

[27]  D. Kem,et al.  Single dose captopril as a diagnostic test for primary aldosteronism. , 1983, The Journal of clinical endocrinology and metabolism.

[28]  K. Ichikawa,et al.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. , 1981, Archives of internal medicine.

[29]  E. Schiffrin,et al.  Role of Ca2+ in response of adrenal glomerulosa cells to angiotensin II, ACTH, K+, and ouabain. , 1981, The American journal of physiology.

[30]  P. Carpenter,et al.  Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. , 1978, The Journal of clinical endocrinology and metabolism.

[31]  J. Laragh,et al.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. , 1972, The New England journal of medicine.

[32]  D. Beevers,et al.  Clinical Hypertension , 2002, Journal of Human Hypertension.

[33]  W. Young.  primary Aldosteronism: Update on Diagnosis and Treatment , 1997 .

[34]  N. Hollenberg,et al.  Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade. , 1992, Endocrine research.

[35]  T. Kollevold,et al.  [Primary aldosteronism]. , 1969, Nordisk medicin.